Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,175 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2360
- Phase 4321
- Phase 1291
- Phase 3288
- Phase 1/Phase 2141
- Phase 2/Phase 364
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University32
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California236
- Maryland147
- Alabama89
- New York76
- Florida74
- Texas61
- Massachusetts56
- Arizona46
- Pennsylvania45
- Illinois42
Recruiting studies4,175 total
- NCT06261840RecruitingPhase 4
Comparing two treatments for trichomonas infection
This trial compares two medicines, metronidazole and secnidazole, to find the best way to treat trichomonas, a common sexually transmitted infection. If you have trichomonas and haven't been treated yet, you may be able to join.
Birmingham, AlabamaAges 18 years+ - NCT06263426Recruiting
Kidney transplant from donors with HIV: impact on rejection and long-term results
This study tests whether kidney transplants from donors with HIV are safe and effective for people with HIV who need a new kidney. It looks at long-term outcomes like rejection and survival.
Birmingham, AlabamaAges 18 years+ - NCT06263439Recruiting
Watching hand, foot, and mouth disease in children
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
Clermont-FerrandAges Up to 10 years - NCT06263959RecruitingPhase 2
Testing a new hepatitis B pill (GST-HG131) for chronic HBV
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
BeijingAges 35–65 - NCT06266416Recruiting
Black caregivers & girls empowerment study
This study tests a program called IMARA to support black male caregivers and the girls they care for. It aims to improve family relationships and reduce risky behaviors in girls.
Chicago, IllinoisAges 13 years+ - NCT06266442Recruiting
DNA study of M. avium in lung infection
This study looks at the DNA of the bacteria causing your lung infection (Mycobacterium avium) to understand treatment better. It involves analyzing stored samples and may include patients who have been treated before.
Toronto, OntarioAges 18 years+ - NCT06272812RecruitingPhase 2
TB vaccine study for teens and adults
This trial tests whether a new vaccine called MTBVAC can prevent tuberculosis (TB) in people living in areas where TB is common. If you are between 14 and 45 years old and in good health, you may be able to join.
KisumuAges 14–45 - NCT06274632Recruiting
Helping Latinos with HIV stay engaged in care
This study tests a program to help Latino adults with HIV who are not yet virally suppressed stay connected to their healthcare. It aims to improve engagement in care and reduce the virus in the body.
Miami, FloridaAges 18 years+ - NCT06274840Recruiting
COVID-19 antibodies in cystic fibrosis
This study looks at how the body makes antibodies (proteins that fight infection) against COVID-19 in people with cystic fibrosis. It helps doctors understand how well your immune system responds to the virus or vaccine.
LisbonAges Any age - NCT06276543Recruiting
Safety study of the Bactiseal shunt catheter
This study is for people who already have a hydrocephalus shunt (a tube that drains fluid from the brain) and have had it for at least 2 years. It tests the safety of a specific catheter called Bactiseal and tracks how well it works over time.
Beijing, Beijing MunicipalityAges Any age - NCT06278337Recruiting
Moesin-associated immunodeficiency study
This study looks at a rare immune system condition caused by changes in the MOESIN gene. It aims to better understand the condition and may help develop future treatments.
Bethesda, MarylandAges 4–80 - NCT06279741RecruitingPhase 1/Phase 2
Cell therapy to prevent lung disease in very premature babies
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
BrusselsAges Up to 1 week - NCT06280872Recruiting
Cord clamping study for moderate and late preterm babies
This trial studies a different way of clamping the umbilical cord after birth to see if it helps moderately preterm babies (born between 32 and 37 weeks). It may improve their health right after delivery.
BrusselsAges 7 months–8 months - NCT06281665RecruitingPhase 4
Aspirin after preeclampsia: the TAP trial
This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06281834RecruitingPhase 1
Dolutegravir levels with TB prevention in children
This study tests how dolutegravir (an HIV medicine) works in children when taken with weekly rifapentine and isoniazid (medicines to prevent tuberculosis). It may help find the right dose for kids who have HIV and are at risk for TB.
Ibadan, Oyo StateAges 4 weeks–11 years - NCT06282315RecruitingPhase 3
Safety of a new deworming pill for children in Ghana and Kenya
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
Accra, AccraAges 5–17 - NCT06282510RecruitingPhase 4
Nasal antisepsis to prevent Candida auris
This trial tests whether a nasal antiseptic can reduce or prevent Candida auris infections in people who have had this germ before. It aims to find a simple way to lower the risk of future infection.
Chicago, IllinoisAges 18 years+ - NCT06283355RecruitingPhase 1
Comparing one vs. multiple nasal treatments in NICU babies
This study tests whether giving one versus multiple doses of a special nasal treatment (called nasal microbiota therapy, or NMT) changes the types of helpful bacteria in your baby's nose. The goal is to see if the treatment keeps bad bacteria, like staph, from growing.
Baltimore, MarylandAges birth–60 years - NCT06283979RecruitingPhase 2
Antibiotic bone filler vs standard care for infected pressure ulcers
This trial tests a special antibiotic bone filler (STIMULAN VG) compared to standard care for people with a serious pressure ulcer that has infected the bone. You need to be able to have surgery to clean and close the wound.
Phoenix, ArizonaAges 18 years+ - NCT06284174Recruiting
Comparing two antiseptics for spinal surgery wound soaking
This trial compares two common antiseptics (povidone-iodine and chlorhexidine gluconate) to see which better reduces germs in spinal surgery wounds during the operation. If you are having lumbar spine surgery, this study may help determine the best way to prevent infections.
Tainan, TaiwanAges 18 years+ - NCT06284473RecruitingPhase 4
Ketamine with numbing medicine for minor emergency procedures
This study tests whether adding ketamine to the usual numbing medicine makes minor procedures in the emergency department less painful. You may be a good fit if you are having a small procedure like stitches or abscess drainage.
Maywood, IllinoisAges 7–70 - NCT06285188Recruiting
Immune monitoring for mold infections
This study tracks how your immune system responds to serious mold infections, like aspergillosis or mucormycosis. It may help doctors understand why some infections are hard to treat and could lead to better care.
ParisAges 18 years+ - NCT06285357Recruiting
Testing EGCG, folic acid, and vitamin B12 for HPV
This trial tests whether taking a combination of EGCG (a compound from green tea), folic acid, and vitamin B12 can help prevent an HPV infection from lasting or getting worse. You may be able to join if you have a high-risk HPV infection but not a more serious cervical cell change called HSIL.
Modena, ModenaAges 25–65 - NCT06286007Recruiting
How whooping cough and RSV affect asthma in adults
This study looks at how infections like whooping cough and RSV impact asthma symptoms and control in adults. It aims to understand if these infections make asthma worse, which could help improve future treatment and prevention.
Santiago de Compostela, A CoruñaAges 18–99
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,175 recruiting infectious disease studies from the U.S. registry right now, out of 7,094 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.